Been watching for some time and recently joined the register.Am...

Been watching for some time and recently joined the register.
Am certainly encouraged by the recent additions to the executive team.
The feedback on their platform and science, from those who would know a lot better than I, is also very encouraging.
Traditionally biotech is a tough sector, but get it even half right and it can be highly lucrative.
Can't see much downside from this low market cap.
But that's just my opinion, DYOR.